Inside the research

Pediatrix Medical Group, Inc.

MD Research profile · latest available data

Price overview

$26.31

▲ +0.65 (+2.5%)

52w hi$27.39
52w lo$15.80
Vol386.00K
As of25 Sep 2026

The Verdict

Hold

Our score +0.30

Short+0.14
Medium+0.42
Long+0.41

computed 2026-09-27

Key fundamentals

Pediatrix Medical Group, Inc.

Healthcare · Medical Care Facilities

Market cap$2.14B
Enterprise value$2.30B
Trailing P/E12.59x
Forward P/E10.78x
EV / EBITDA8.73x
P / S (ttm)1.10x
Profit margin9.0%
Return on equity20.4%
Revenue growth+4.0%
Earnings growth+6.5%
Debt / equity70.37

Layer Breakdown

LayerRawContribution
Fundamental+0.28
Sector+0.08
Technical+0.14
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

United States · www.pediatrix.com

Risk Metrics

Beta vs SPX0.73
Corr SPX0.25
Annual vol46.8%
Annual ret+56.1%
Sharpe1.20
Max DD-30.5%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-08-04Earnings Release, Exhibitsread
2026-07-24Officer / Director Change, Reg FD Disclosureread
2026-07-15Earnings Release, Reg FD Disclosure…read
2026-05-07Officer / Director Change, Shareholder Vote…read
2026-05-05Earnings Release, Exhibitsread
2026-02-19Earnings Release, Exhibitsread
2025-11-03Earnings Release, Exhibitsread
2025-08-18Reg FD Disclosure, Other Material Event…read
2025-08-05Earnings Release, Exhibitsread
2025-07-01Officer / Director Change, Reg FD Disclosure…read
2025-05-08Shareholder Voteread
2025-05-06Earnings Release, Exhibitsread

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders7
Top-5 share99.2%
HHI3,562 (concentrated)

Top Holders

HolderValueShares
State Street Corp$89.50M3.53M
Renaissance Technologies$32.61M1.29M
Fidelity / FMR LLC$18.78M741.39K
AQR Capital Management$11.53M471.29K
Capital Research / Capital World$11.04M435.82K
Millennium Management$1.40M55.12K
T. Rowe Price Group$2.84K112.02K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-144view
2026-08-144view
2026-08-144view
2026-08-144view
2026-08-144view
2026-08-144view
2026-08-144view
2026-08-144view
2026-08-048-Kview
2026-08-0410-Qview
2026-07-248-Kview
2026-07-158-Kview
2026-06-243view
2026-06-244view
2026-06-104view

The Long Run

FY 2010–2025 · 16 years

LineLatestCAGRTrend
Operating income$208.81M-2.7%
Net income$165.39M-0.2%
Cash from ops$137.32M-5.0%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$25.66$26.34$25.66$26.31386.00K
Sep 24$26.25$26.25$25.55$25.66732.60K
Sep 23$26.23$26.40$25.79$25.86454.00K
Sep 22$25.61$26.49$25.61$26.35818.00K
Sep 21$26.06$26.06$25.30$25.77506.80K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →